Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Pelizaeus-Merzbacher disease-associated proteolipid protein 1 inhibits oligodendrocyte precursor cell differentiation via extracellular-signal regulated kinase signaling.
Efficient in vivo depletion of CD8(+) T lymphocytes in common marmosets by novel CD8 monoclonal antibody administration.
Sexual disparities in the incidence and course of MS.
Interest in providing multiple sclerosis care and subspecializing in multiple sclerosis among neurology residents.
Bipolar disorder and multiple sclerosis: a case series.
Never-resting microglia: physiological roles in the healthy brain and pathological implications.
Teva Presents New Clinical Safety Data in RRMS Patients Treated with Laquinimod for Two or More Years at Joint ACTRIMS-ECTRIMS Meeting
Therapeutic Yoga: Symptom Management for Multiple Sclerosis.
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-establishing disease prognosis and monitoring patients.
Treatment Effects Maintained Over Five Years in Majority of Patients with Relapsing Remitting Multiple Sclerosis who Received Genzyme’s Lemtrada® (alemtuzumab) in Clinical Trials
Association of circulating follicular helper T cells with disease course of NMO spectrum disorders.
The immunogenetics of multiple sclerosis: A comprehensive review.
We are about to cure multiple sclerosis in the next 10 years, even though we do not know its cause: Yes.
Contextualized perceptions of movement as a source of expanded insight: People with multiple sclerosis' experience with physiotherapy.
Acute Disseminated Encephalomyelitis Following 2009 H1N1 Influenza Vaccination.
Multiple sclerosis: Efficacy of fingolimod confirmed on all MRI end points.
Theiler's murine encephalomyelitis virus induced phenotype switch of microglia in vitro.
Vascular pathology of multiple sclerosis.
Neuromyelitis optica.
The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells.
Paracaspase MALT1 Deficiency Protects Mice from Autoimmune-Mediated Demyelination.
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination.
Injury to a specific neural pathway detected by Ultra-high-field MRI.
Phenytoin in acute optic neuritis: neuroprotective or not?
Complex assessment in progressive multiple sclerosis: a case report.
Pages
« first
‹ previous
…
326
327
328
329
330
331
332
333
334
…
next ›
last »